Juliette (Cyproterone Acetate, Ethinylestradiol)

Cyproterone acetate acts as a progestogen and an anti‑androgen. It suppresses the release of gonadotropins from the pituitary, which blocks the mid‑cycle surge of luteinising hormone required for ovulation, while also counteracting androgen effects that can cause acne or hirsutism.

The dosing regimen for Juliette is determined by the prescribing clinician. Typically, it is taken as a daily oral tablet following the specific cycle schedule indicated on the prescription, but the exact dose and duration should always be confirmed with a qualified healthcare professional.

Juliette is classified as pregnancy category X, meaning it must not be used during pregnancy because it can cause fetal harm. It is also not recommended while breastfeeding, as hormones may pass into breast milk and affect the infant. Women should consult their doctor for alternative options.

To order Juliette, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials before providing pricing, availability, shipping details and any necessary import documentation.

Juliette contains cyproterone acetate, which provides additional anti‑androgenic activity compared with many other combined pills that use levonorgestrel or desogestrel. This can be advantageous for patients with acne or hirsutism, while its contraceptive efficacy remains comparable to other estrogen‑progestogen combinations.

Juliette tablets should be stored at room temperature, below 25 °C, in the original blister pack. Keep them away from moisture, heat and direct sunlight to maintain product stability throughout the shelf life.

Juliette is taken orally, usually once daily at the same time each day. The tablets are swallowed whole with water and should be started according to the prescribing schedule, often on the first day of the menstrual period or as directed by a healthcare provider.

The most serious risks include venous thromboembolism, pulmonary embolism, stroke, myocardial infarction, severe liver dysfunction and allergic reactions such as anaphylaxis. Patients should seek immediate medical attention if they experience symptoms like sudden chest pain, shortness of breath, severe abdominal pain, or skin rash.

Juliette is contraindicated in women who are pregnant, have a history of thromboembolic disorders, uncontrolled hypertension, severe liver disease, known hypersensitivity to any component, or who smoke heavily and are over 35 years old. A thorough medical assessment is required before initiating therapy.